• Explore /
  • Poster
  • / BOLD-100-001 (TRIO039): A phase 1b/2a study of BOLD-100 in combination with FOLFOX chemotherapy in patients with pre-treated advanced gastric and biliary tract cancer: Efficacy and safety analysis.

BOLD-100-001 (TRIO039): A phase 1b/2a study of BOLD-100 in combination with FOLFOX chemotherapy in patients with pre-treated advanced gastric and biliary tract cancer: Efficacy and safety analysis.

Abstract Poster

Authors

Grainne M. O'Kane

Grainne M. O'Kane

Trinity St. James’s Cancer Institute, Dublin, Ireland

Grainne M. O'Kane , Jennifer L. Spratlin , Do-Youn Oh , Sun Young Rha , Elena Elimova , Petr Kavan , Moon Ki Choi , Rachel Anne Goodwin , Seung Tae Kim , Dong-Hoe Koo , Khalif Halani , E Russell McAllister , Michelle Jones , Malcolm Snow , Yasmin Lemmerick , Gonzalo Spera , Jim Pankovich

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT04421820

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4098)

DOI

10.1200/JCO.2023.41.16_suppl.4098

Abstract #

4098

Poster Bd #

419

Abstract Disclosures

Similar Posters

First Author: Jennifer L. Spratlin

First Author: Grainne M. O'Kane

First Author: Grainne M. O'Kane

First Author: Matthieu Delaye